Drug-delivery technology firm Mercator MedSystems Inc. named Trent Reutiman its CEO on April 14. Reutiman, who was also appointed to the venture-backed, San Leandro, Calif., firm’s board, was most recently VP of global commercial operations for IDev Technologies Inc., which was acquired by Abbott Laboratories Inc. last year. (See Also see "Abbott Ups Vascular, Ophthalmic Focus With Two Acquisitions" - Medtech Insight, 15 July, 2013..) Previously, Reutiman has worked at Rox Medical Inc., Rita Medical Systems Inc., Guidant Corp., and Cordis Corp. Mercator sells the 510(k)-cleared Cricket and Bullfrog micro-infusion devices for targeted delivery of drugs and biologics.
The Medical Imaging & Technology Alliance says it has appointed former HHS health information technology official Thad Flood to the title of industry director. He will replace Richard Eaton, who...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?